Issues in Randomization - PowerPoint PPT Presentation

1 / 61
About This Presentation
Title:

Issues in Randomization

Description:

Smoking is a known risk factor for pancreatic cancer. Smoking is associated with coffee drinking ... Non-comparability of groups. No placebo/control = problems ... – PowerPoint PPT presentation

Number of Views:80
Avg rating:3.0/5.0
Slides: 62
Provided by: LauraLee9
Category:

less

Transcript and Presenter's Notes

Title: Issues in Randomization


1
Issues in Randomization
  • Laura Lee Johnson, Ph.D.
  • Biostatistician
  • National Cancer Institute
  • Introduction to the Principles and Practice of
    Clinical Research
  • Monday, October 25, 2004

2
Biostatistics
  • Randomization
  • Hypothesis Testing
  • Sample Size and Power
  • Survival Analysis

3
Objectives
  • Intuitive understanding of the statistics used in
    clinical research
  • Understand and perform some simple but useful
    analyses sample size calculations
  • Learn how to collaborate effectively with
    statisticians

4
Objectives Randomization Lecture
  • Reasons for randomization
  • Randomization theory and mechanisms
  • Types of randomized study designs
  • Compare randomized experimental studies to
    nonrandomzied observational studies
  • Nonrandomized experimental studies

5
Outline
  • Introductory Statistical Definitions
  • What is Randomization?
  • Randomized Study Design
  • Experimental vs. Observational
  • Non-Randomized Study Design
  • Statistical Software, Books, Articles

6
Words I Might Use
  • Phase I, II, IIb, III, IV Trial
  • Model y ß0 ß1x1 ß2x2 e
  • Covariate
  • Effect Modifier
  • Confounder

7
Confounding
  • Two or more variables
  • Known or unknown to the researchers
  • Confounded when their effects on a common
    response variable or outcome are mixed together

8
Confounding Example
  • Relationship between coffee and pancreatic
    cancer, BUT
  • Smoking is a known risk factor for pancreatic
    cancer
  • Smoking is associated with coffee drinking but it
    is not a result of coffee drinking.

9
What is confounding?
  • If an association is observed between coffee
    drinking and pancreatic cancer
  • Coffee actually causes pancreatic cancer, or
  • The coffee drinking and pancreatic cancer
    association is the result of confounding by
    cigarette smoking.

10
How to handle confounding
  • If you know something is a possible confounder,
    in the data analysis use
  • Stratification, or
  • Adjustment
  • Fear the unknown!

11
Study Design Taxonomy
  • Treatment vs. Observational
  • Prospective vs. Retrospective
  • Longitudinal vs. Cross-sectional
  • Randomized vs. Non-Randomized
  • Blinded/Masked or Not
  • Single-blind, Double blind, Unblinded

12
Outline
  • Introductory Statistical Definitions
  • What is Randomization?
  • Randomized Study Design
  • Experimental vs. Observational
  • Non-Randomized Study Design
  • Stat Software, Books, Articles

13
Randomization Definition
  • Random Allocation
  • known chance receiving a treatment
  • cannot predict the treatment to be given
  • Eliminate Selection Bias
  • Similar Treatment Groups

14
ONE Factor is Different
  • Randomization tries to ensure that ONE factor is
    different between two or more groups.
  • Observe the Consequences
  • Attribute Causality

15
Types of Randomization
  • Standard ways
  • Random number tables (see text)
  • Computer programs
  • NOT legitimate
  • Birth date
  • Last digit of the medical record number
  • Odd/even room number

16
Types of Randomization
  • Simple
  • Blocked Randomization
  • Stratified Randomization

17
Simple Randomization
  • Randomize each patient to a treatment with a
    known probability
  • Corresponds to flipping a coin
  • Could have imbalance in / group or trends in
    group assignment
  • Could have different distributions of a trait
    like gender in the two arms

18
Block Randomization
  • Insure the of patients assigned to each
    treatment is not far out of balance
  • Variable block size
  • An additional layer of blindness
  • Different distributions of a trait like gender in
    the two arms possible

19
Stratified Randomization
  • A priori certain factors likely important (e.g.
    Age, Gender)
  • Randomize so different levels of the factor are
    balanced between treatment groups
  • Cannot evaluate the stratification variable

20
Stratified Randomization
  • For each subgroup or strata perform a separate
    block randomization
  • Common strata
  • Clinical center, Age, Gender
  • Stratification MUST be taken into account in the
    data analysis!

21
When to Randomize?
  • When the treatment must change!
  • SWOG 1 vs. 2 years of CMFVP adjuvant
    chemotherapy in axillary node-positive and
    estrogen receptor-negative patients.
  • JCO, Vol 11 No. 9 (Sept), 1993

22
Randomize at the Time Trial Arms Diverge
  • SWOG randomized at beginning of treatment
  • Discontinued treatment before relapse or death
  • 17 on 1 year arm
  • 59 on 2 year arm
  • Main reason was patient refusal

23
Outline
  • Introductory Statistical Definitions
  • What is Randomization?
  • Randomized Study Design
  • Experimental vs. Observational
  • Non-Randomized Study Design
  • Stat Software, Books, Articles

24
Types of Randomized Studies
  • Parallel Group
  • Sequential Trials
  • Group Sequential trials
  • Cross-over
  • Factorial Designs

25
Parallel Group
  • Randomize patients to one of k treatments
  • Response
  • Measure at end of study
  • Delta or change from baseline
  • Repeated measures
  • Function of multiple measures

26
Ideal Study - Gold Standard
  • Double blind
  • Randomized
  • Parallel groups

27
Sequential Trials
  • Not for a fixed period
  • Terminates when
  • One treatment shows a clear superiority or
  • It is highly unlikely any important difference
    will be seen
  • Special statistical design methods

28
Group Sequential Trials
  • Popular
  • Analyze data after certain proportions of results
    available
  • Early stopping
  • If one treatment clearly superior
  • Adverse events
  • Careful planning and statistical design

29
Crossover Trial
  • E.g. 2 treatments 2 period crossover
  • Use each patient as own control
  • Must eliminate carryover effects
  • Need sufficient washout period

30
Factorial Design
  • Each level of a factor (treatment or condition)
    occurs with every level of every other factor
  • Selenomethionine and Celecoxib Gastroenterology
    2002 122A71

31
Incomplete Factorial Trial
  • Nutritional Intervention Trial (NIT)
  • 4x4 incomplete factorial
  • A,B,C,D
  • Did not look at all possible interactions
  • Not of interest (at the time)
  • Sample size prohibitive

32
Outline
  • Introductory Statistical Definitions
  • What is Randomization?
  • Randomized Study Design
  • Experimental vs. Observational
  • Non-Randomized Study Design
  • Stat Software, Books, Articles

33
Observational Experimental
  • Can ONLY show Association
  • You will never know all the possible confounders!
  • Can show Association and Causality
  • Well done randomization means unknown confounders
    should not create problems

34
Observational Studies
  • Cohort Study
  • Follow a group for a while
  • Cardiovascular Health Study
  • Case-Control Study
  • Groups with or without outcome
  • Determine who was exposed to risk factor

35
Observational Studies
  • Cross-sectional
  • Collect a representative sample
  • Simultaneously classify by outcome and risk factor

Outcome
No disease
Disease
Y
Risk Factor
N
36
Observational Studies are Useful
  • May be only alternative
  • Smoking in humans
  • What happens in free living people
    (Cardiovascular Health Study)
  • May be cheaper and faster than a trial

37
Do not always agree
  • HRT
  • Observational trials
  • WHI
  • Publication bias?

38
Outline
  • Introductory Statistical Definitions
  • What is Randomization?
  • Randomized Study Design
  • Experimental vs. Observational
  • Non-Randomized Study Design
  • Stat Software, Books, Articles

39
Nonrandomized Experimental Studies
  • No control group
  • Early in investigation
  • Concurrent control group
  • Treatment assignment not by randomization
  • Historically controlled
  • Missing/poor data
  • Non-comparability of groups

40
No placebo/control problems
  • Patients tend to do better by receiving some
    treatment, even placebo or standard of care (soc)
  • Comparing a patient on treatment to baseline does
    not take this into account

41
Additional Problems
  • Researchers tend to interpret findings in favor
    of the new treatment
  • Investigator bias
  • Impossible to distinguish the effect of time from
    treatment effects
  • Confounding

42
Human Assumptions and Concurrent Control Groups
  • Newer better
  • Systematic allocation is unreliable and many
    times NOT systematic
  • Bias
  • Manipulation
  • No randomization ? impossible to establish if
    comparable groups

43
Historical Control Study
  • Small patient pool
  • Pediatrics
  • Cancer research
  • Responses compared to controls from previous
    studies.
  • Only half the patients
  • No placebo exposure

44
Historical Control Problems
  • Serious bias for assessing treatment efficacy
  • Controls not a good comparison group

45
Historical Controls and Time
  • Treatments, technology, patient care changed over
    time
  • Patient population characteristics have changed
    over time

46
Non-randomized Phase II design problems
  • Placebo effect
  • Investigator bias
  • Unblinded treatment
  • Regression to the mean
  • Natural reduction in disease activity over time

47
Observational Studies
  • Why can observational studies only find a weaker
    degree of connection?
  • Subject to confounding
  • Can correct for what you know, but nothing to be
    done about the unknown
  • Sometimes it is unethical to do a randomized
    trial (e.g. smoking)

48
Causation vs. Association
  • Causation
  • Established by experimental studies and clinical
    trials
  • Association
  • Observation studies can merely find association
    between a risk factor and an response

49
Outline
  • Introductory Statistical Definitions
  • What is Randomization?
  • Randomized Study Design
  • Experimental vs. Observational
  • Non-Randomized Study Design
  • Stat Software, Books, Articles

50
Statistical Resources
  • Software
  • Books
  • Articles, etc.

51
Software
  • Most is expensive and some have yearly license
    fees
  • NIH (through CIT) many times has the software for
    free or cheaper than retail
  • Some is hard to use, some is easy

52
Software Programming Options
  • S-PLUS (Windows/UNIX) Strong academic and NIH
    following extensible comprehensive
  • www.insightful.com
  • R (Windows/Linux/UNIX/Mac) GNU similar to
    S-PLUS
  • www.r-project.org
  • www.bioconductor.org

53
S and R
  • Produce well-designed publication-quality plots
  • Code from C,C, Fortran can be called
  • Active user communities

54
Statistical Calculators
  • www.stat.ucla.edu
  • Statistical Calculators

55
Other Software
  • STATA (Windows/Mac/UNIX)
  • Good for general computation, survival,
    diagnostic testing
  • Epi friendly
  • GUI/menu and command driven
  • Active user community
  • www.stata.com

56
Other Software
  • SAS (Windows/UNIX)
  • Command driven
  • Difficult to use, but very good once you know how
    to use it
  • Many users on the East coast
  • www.sas.com
  • SPSS, EpiCure, many others

57
Books
  • Statistical Rules of Thumb by Gerald van Belle
  • Epidemiology by Leon Gordis
  • The Statistical Evaluation of Medical Tests for
    Classification and Prediction by Margaret
    Sullivan Pepe

58
More Books
  • Hosmer and Lemeshow books
  • Statistical Reasoning in Medicine The Intuitive
    P-Value Primer by Lemuel Moye
  • Designing Clinical Research An Epidemiologic
    Approach, edited by Stephen Hulley

59
And More Books
  • Data Monitoring Committees in Clinical Trials A
    Practical Perspective by Ellenberg, Fleming,
    DeMets.
  • Fundamentals of Clinical Trials by Friedman,
    Furberg, DeMets

60
Articles
  • British Medical Journal Statistics Notes
  • http//www.sghms.ac.uk/depts/
  • phs/staff/jmb/pbstnote.htm
  • Statistics in Medicine
  • NEJM Equivalence trials
  • October 16, 1997

61
Questions?
Write a Comment
User Comments (0)
About PowerShow.com